Objective
To achieve positive absolute performance and superior long-term capital appreciation, with a focus on forming, building, and supporting world-class life sciences, biopharmaceutical and medical technology companies.
Management group
RTW Investments
Launch date
29/10/2019
Domicile
Guernsey
Fund manager
Naveen Yalamanchi, Roderick Wong, Stephanie Sirota, Sabera Loughran
Dividend frequency
Data Not Available
Wind-up provisions
The Company has an unlimited life.
Market Cap (m) Total assets (m) Price (last close) NAV Discount / premium (%) Gearing (%) Dividend yield (%) Dividend dates Ongoing charge (%)
553.59 676.61 1.44 1.76 -18.18 0 0.00 N/A 1.87 (31/12/2023)
Scroll

Note

Dividends

Dividends declared in last 12 months

There have been no dividends in the last 12 months.

Performance (%)

Return type 1 year 3 years 5 years 10 years
RTW Biotech Opportunities Share price total return 16.6 -29.8 N/A N/A
Biotechnology & Healthcare AIC sector Share price total return -3.1 -15.8 5.3 129.0
Scroll

Share structure

Number of shares
384,436,512

Traded volumes (number of shares)

  Yesterday 1 month 1 year 5 years
Total 336,002 11,818,894 99,568,569 0
Average N/A 547,449 393,193 0
Scroll

Traded values (m)

  Yesterday 1 month 1 year 5 years
Total 0.48 16.08 129.65 0
Average N/A 0.75 0.51 0
Scroll

Trading details

ISIN TIDM Traded currency Stock exchange
GG00BKTRRM22 RTW USD London Stock Exchange - MAIN
Chi-x Europe Limited
London Stock Exchange
Scroll

Top holdings

Data as at : 30/06/2022

Investment % of total assets
Other Assets And Liabilities 28.5
Rocket 10.3
Ji Xing 7.7
Equity Swaps 5.9
Rtw Royalty Holdings 2 4.6
Prometheus Biosciences 4.2
Immunocore 3.8
Avidity 3.2
Beta Bionics 1.8
Ni Kang 1.4

Morningstar logo Data provided by Morningstar.

FE fundinfo logo Company documents provided by FE fundinfo.